Drugs with this side effect
- 1,25(OH)2D3
- 17-hydroxyprogesterone: 0.7% - 2.3%
- 4-methylpyrazole
- 5-ASA: postmarketing, rare, 0% - 40%
- 5-FU
- 5-aminolevulinic acid
- 5-aza-2'-deoxycytidine: 16% - 33.7%
- 5-azacytidine: very common, 14.1% - 36.4%
- 5-fluorocytosine
- 6-mercaptopurine
- 68Ga
- A77 1726: 17.9% - 18%
- ACTH(1-39: 3%
- ALX 111
- AMD3100: very common, 0% - 37%
- APAs
- Abarelix: 11.1%
- Anidulafungin: 1.6% - 18.4%
- Asp-Tyr(SO3H)-Met-Gly-Trp-Met-Asp-Phe-NH2
- Azarga
- BCNU: 2% - 1-10%
- BPTI
- Benicar-HCT
- Buscopan
- CAS 76095-16-4: 1.4% - 2.1%
- CAS 76420-72-9
- CGP 19835A: very common, 13%
- Cancidas: 0.8% - 27%
- Carfilzomib: 0.19% - 32.7%
- Colimycin M
- D-penicillamine
- Depreotide
- Diane-35
- EACA
- EDTA
- Enfuvirtide: 26.8% - 33.5%
- Estrofem
- FAMP: 13% - 15%
- FK463: 7.14% - 64.6%
- FTY720: very common, 11.8% - 12%
- FdUrd
- Fe(III: postmarketing, 2% - 35%
- Forteo: 5.1%
- Gd-DTPA
- Ge-132: 14% - 37%
- Goserelin: 1.28% - 40%
- Humalog: 5.81% - 8.64%
- ICI 182,780: postmarketing, 12.3% - 12.8%
- Implanon: postmarketing
- Insulin: 0.402% - 3.18%
- K779: 2% - 45%
- Kaluril
- L-Dmp: 1%
- LMWH: 2.2%
- LY146032: postmarketing, common, 1.7% - 18.1%
- Lantus: 10.3% - 10.7%
- Leuprorelin
- LiOH
- Lisinopril: postmarketing, common, 1.8% - 6.1%
- Lu AA21004: 7% - 10%
- Lutalyse
- Lyxumia
- MDV3100: 1.1% - 21.8%
- MK-462
- Madopar
- Meropenem anhydrous: 4.8% - 7%
- Mersyndol
- Metrodin: postmarketing, common, 0% - 7.6%
- N-carbamylglutamate: uncommon
- NTBC
- Nafarelin
- NovoLog: 2% - 8%
- NuvaRing
- Nuvocid: 3.26% - 3.69%
- Octreotide: very common, 3.1% - 57.9%
- Oestrogen: 6% - 7%
- Optison: uncommon
- PCI-32765: 2% - 48%
- PGE1: 1% - 11%
- PGE2
- Paroven
- Photofrin: 4% - 10.1%
- Photofrin II: common
- Promacta: 12.6%
- Refludan
- Romidepsin: 0.98% - 36.2%
- SOM230: 57.5% - 58.5%
- SU5416
- Sativex
- Signifor: 57.5% - 58.5%
- Stalevo 50
- Supremon
- T-A2-3
- TMC207
- TPGS
- TR-700: 4% - 5%
- Terlipressin: postmarketing
- Timentin
- TlCl
- Triphasil
- Triptorelin: 1.1% - 1.4%
- UDCA: postmarketing, 25.2% - 27.1%
- VACV: postmarketing, rare, 1% - 23%
- Vitrum: 0.102% - 1%
- abacavir: common, 5.47% - 18%
- abacavir-lamivudine: common
- abiraterone: 0.6% - 1.3%
- acamprosate: very common, 10% - 17%
- acarbose: postmarketing
- acebutolol: 1% - 5%
- acenocoumarol
- acetaminophen: 1.3%
- acetazolamide
- acipimox
- acitretin: postmarketing
- aclidinium bromide: 2.67%
- actinomycin D: 30%
- acyclovir: postmarketing, common, 1.5% - 5%
- adefovir: 3%
- adefovir dipivoxil: postmarketing, common, 3%
- afatinib: very common, 0% - 96%
- agomelatine
- alendronate: 0% - 3.1%
- alfuzosin: postmarketing, uncommon
- aliskiren: common, 1.66% - 3.82%
- allopurinol
- almotriptan: infrequent
- alpha-methyl-p-tyrosine
- alprazolam: frequent, 1.2% - 22.8%
- amantadine: rare
- ambrisentan
- amiloride: 3.8%
- aminophylline: 0% - 14%
- amiodarone: 0.983% - 1.17%
- amisulpride: 1%
- amitriptyline
- amlodipine
- amlodipine besylate
- amoxapine
- amoxicillin: common, 1.66% - 8%
- amphetamine
- amphotericin B: 3.49% - 30.3%
- ampicillin
- amprenavir: very common, 5% - 60%
- amsacrine
- anagrelide: 24% - 25.7%
- anastrozole: 2.77% - 8.57%
- anthracycline: 4% - 34%
- apomorphine
- apraclonidine
- apremilast: 1.8% - 9.26%
- aprepitant: 0.9% - 10.3%
- argatroban: 0% - 11%
- aripiprazole: 0% - 5%
- arsenic
- arsenic trioxide: common
- articaine
- aspirin
- atazanavir: postmarketing, common, 1% - 11%
- atenolol: 2% - 3%
- atomoxetine: 3% - 4%
- atorvastatin: 0% - 6.8%
- atovaquone: 0.2% - 42%
- atropine
- auranofin: postmarketing, 13% - 47%
- avanafil
- axitinib: 7% - 55%
- azathioprine: very rare
- azelastine
- azilsartan: 2%
- azilsartan medoxomil
- azithromycin: postmarketing, 4% - 52.8%
- aztreonam: 1.4%
- baclofen: common, 0% - 2.3%
- balsalazide: 3.7% - 11.4%
- barium
- barium sulfate
- belinostat: 2% - 23%
- benazepril
- bendamustine: 0% - 37%
- bendrofluazide
- benzphetamine
- bepridil: 0% - 10.9%
- betahistine: rare
- betaine: postmarketing, uncommon
- betaxolol: postmarketing, 1.9% - 8%
- bethanechol
- bexarotene: 1% - 41.5%
- bezafibrate: 9% - 16%
- bicalutamide: postmarketing, common, 10%
- bile salt
- bisacodyl
- bisoprolol: postmarketing, common, 2.6% - 3.5%
- boceprevir: very common, 15% - 22%
- bortezomib: 0% - 57.4%
- bosentan: uncommon
- bosutinib: 9.1% - 82%
- bretylium
- brinzolamide: postmarketing
- bromcresol green
- bromhexine
- bromocriptine: postmarketing, rare, 0.4% - 3%
- budesonide: 2% - 10%
- bumetanide
- bupivacaine: 0.982% - 1.32%
- buprenorphine: 2.21% - 10.3%
- bupropion: 3% - 7%
- buspirone: 2%
- busulfan: 58% - 84%
- cabazitaxel: 1% - 46.6%
- cabergoline: 1.81% - 4.3%
- cabozantinib
- calcium
- candesartan
- candesartan cilexetil: 0.9% - 1.6%
- capecitabine: 1% - 65%
- captopril
- carbachol
- carbamazepine: postmarketing, uncommon, common, 10%
- carbenicillin
- carbidopa: 0.6% - 1.2%
- carbinoxamine
- carboplatin: 6%
- carboprost
- carnitine: 9% - 35%
- carvedilol: 0.3% - 12%
- cefaclor: 2.67% - 4.08%
- cefadroxil
- cefazolin: postmarketing
- cefdinir
- cefditoren
- cefepime: 1.2% - 3%
- cefixime: 15% - 16%
- cefotaxime
- cefotetan
- cefoxitin
- cefprozil: 2.7% - 2.9%
- ceftaroline
- ceftazidime: common
- ceftizoxime
- ceftobiprole: 0.5% - 4.8%
- ceftriaxone: 2.7% - 3.3%
- cefuroxime
- cefuroxime axetil
- celecoxib: 4% - 10.5%
- celiprolol
- cephalexin
- cephem
- cerivastatin: 3.3%
- cetirizine: postmarketing, 1.9% - 3.51%
- cevimeline: 10.3%
- chlorambucil: 1%
- chloramphenicol
- chloride
- chloroquine
- chlorpheniramine
- chlorpropamide
- chlorthalidone: rare
- choline theophyllinate
- cidofovir: postmarketing, 26.1%
- cilazapril
- cilostazol: 12% - 19%
- cimetidine: common, 1.8%
- cinacalcet: postmarketing, uncommon, 21%
- cinoxacin
- ciprofloxacin: postmarketing, rare, common, 1% - 2.3%
- cisplatin
- citalopram: 4.4% - 14%
- citric acid: postmarketing
- cladribine: very common, 7% - 3-12%
- clarithromycin: postmarketing, common, 3% - 7%
- clemastine
- clindamycin: postmarketing
- clindamycin phosphate
- clobazam: 1.4%
- clodronate: 2-10%
- clofarabine: very common, 20%
- clofazimine
- clomiphene citrate
- clomipramine: common, 7% - 13%
- clonazepam
- clonidine: 1% - 4%
- clopidogrel: postmarketing, common
- clozapine: 2%
- cobicistat: common
- colchicine: postmarketing, 23% - 76.9%
- colesevelam: 5%
- colestimide: common
- colestipol
- colestyramine: common
- conivaptan
- conjugated estrogens
- copolymer 1
- cortisol
- crizotinib: 0% - 60%
- cyanocobalamin
- cyclobenzaprine
- cyclophosphamide
- cyproheptadine
- cyproterone
- cyproterone acetate
- cysteamine: postmarketing, very common, 16% - 31%
- cytarabine: 11% - 32.1%
- d-telaprevir: common, 17%
- dabigatran
- dabigatran etexilate
- dabrafenib: very common, 0% - 36%
- dacarbazine: 1%
- dalbavancin: 4.4% - 5.88%
- dalteparin: 0.578% - 1.34%
- dantrolene
- darifenacin: 2.1%
- darunavir: 2.3% - 24%
- dasatinib: 0% - 31%
- deferasirox: common, 4.55% - 47.4%
- deferiprone
- deferoxamine: very rare
- degarelix
- delamanid
- delavirdine
- delta 9-THC
- demeclocycline
- demethyl
- deprenyl: 1% - 9%
- desipramine
- desloratadine
- desmopressin: 0.15% - 2%
- desogestrel
- desvenlafaxine: 11%
- dexamethasone
- dexamethasone sodium phosphate
- dexmedetomidine: postmarketing
- dexpanthenol
- dexrazoxane: 7% - 22%
- dextromethorphan
- diatrizoate
- diazepam
- diazoxide
- diclofenac: postmarketing, rare, common, 0% - 6%
- dicloxacillin
- didanosine: 15% - 28%
- diethylenetriaminepentaacetic acid
- diethylpropion
- diflunisal
- digoxin: 3.25% - 4%
- dihydrocodeine: uncommon
- dihydroergotamine: postmarketing, 2%
- diltiazem: 1.34% - 2.08%
- dimercaptosuccinic acid
- diphenhydramine
- dipyridamole: 9.3%
- disopyramide
- docetaxel: 0.9% - 77.8%
- dofetilide: 3%
- dolasetron: 2.13% - 12.7%
- dolutegravir: 1% - 16%
- domperidone
- donepezil: 0% - 15%
- doripenem: common, 0.1% - 14%
- dorzolamide
- dothiepin
- doxapram
- doxazosin: 2% - 3.8%
- doxepin
- doxorubicin: postmarketing, very common, 0% - 50.7%
- doxycycline: postmarketing, 1% - 5.63%
- doxycycline calcium
- doxycycline hyclate: 5.63%
- dronedarone: 9%
- duloxetine: 7% - 13%
- dyphylline
- ecallantide: 4% - 11%
- edrophonium
- efavirenz: common, 2% - 14%
- eletriptan: infrequent
- eliglustat: 3.77% - 12.3%
- eltrombopag: 9% - 21%
- elvitegravir: common, 7.1%
- emtricitabine: postmarketing, very common, 5% - 20%
- entacapone: common, 8% - 10%
- entecavir: uncommon, common, 0% - 1%
- eplerenone: common, 2%
- eprosartan
- ergonovine
- eribulin: 0% - 18%
- erlotinib: 0% - 62%
- ertapenem: 4.2% - 17%
- erythromycin
- erythromycin lactobionate
- erythromycin stearate
- eslicarbazepine
- eslicarbazepine acetate
- esomeprazole magnesium: 2% - 9.2%
- estradiol: postmarketing, 1.12% - 5.37%
- estramustine: 11% - 12%
- estramustine phosphate
- ethacrynic acid
- ethionamide
- ethosuximide
- ethotoin
- etidronate
- etodolac
- etoposide: 6% - 1-13%
- etoposide phosphate: 6%
- etoricoxib
- etravirine: 5.2%
- everolimus: common, very common, 0% - 50%
- exemestane: common, 4% - 9.6%
- exenatide: postmarketing, rare, 3.59% - 20%
- ezetimibe: 2.2% - 4.1%
- famciclovir: 1.3% - 9%
- famotidine: 1.6% - 2.9%
- febuxostat
- felbamate: 0% - 5.3%
- felodipine
- fenofibrate: common, 0.533% - 6.94%
- fenofibric acid: 3.06% - 6.94%
- fenoldopam
- fenoprofen
- fentanyl: very rare, postmarketing, 0% - 15.8%
- ferumoxytol: postmarketing, 4%
- fesoterodine
- fexofenadine: 0.8% - 3.7%
- flecainide
- flucloxacillin
- fluconazole: postmarketing, 0.5% - 3%
- fludarabine: 5% - 15%
- fludrocortisone acetate
- flunisolide
- fluocinolone acetonide
- fluoxetine: infrequent, very common, 2% - 18.2%
- flurazepam
- flurbiprofen
- flutamide: 36% - 40%
- fluticasone: 0% - 1.36%
- fluticasone furoate: 2.81%
- fluticasone propionate
- fluvastatin: 0.2% - 4.9%
- fluvoxamine: common, frequent, 1% - 18%
- fondaparinux: rare, 0.5% - 2.58%
- formoterol: 6%
- fosamprenavir: common
- fosaprepitant dimeglumine
- foscarnet
- fosfomycin: 3.1% - 9%
- fosfomycin trometamol
- fosinopril: uncommon
- fosinoprilat
- fosphenytoin: infrequent
- fotemustine
- frovatriptan: frequent
- furosemide
- fusidic acid: 3% - 7.9%
- gabapentin: postmarketing, 1.3% - 46%
- gadobenate dimeglumine
- gadobutrol
- gadodiamide
- gadofosveset
- gadolinium: postmarketing, 1.91%
- gadopentetate
- gadoversetamide: 0.722% - 1.91%
- galantamine: 2% - 12%
- ganciclovir: 24.4% - 41%
- gatifloxacin
- gefitinib: very common, 0% - 66.7%
- gemcitabine: common, 0% - 34%
- gemeprost: 3%
- gemfibrozil: 4.9% - 7.2%
- gemifloxacin: 0.3% - 4.6%
- glibenclamide
- gliclazide: 2% - 2.5%
- glimepiride
- glipizide: 5.4%
- glycerol phenylbutyrate: 6.67% - 15.9%
- glycine
- gold sodium thiomalate
- gonadorelin: common, 1.97% - 2.54%
- granisetron: 3.4% - 25.6%
- griseofulvin
- guanfacine: postmarketing, 4%
- guanidinium
- halofantrine: 5% - 6%
- haloperidol
- hepatitis B vaccines: common
- histamine
- hydralazine: common
- hydrochlorothiazide
- hydroflumethiazide
- hydromorphone: 2.91% - 8.12%
- hydroxocobalamin
- hydroxybutyrate: 3% - 4%
- hydroxychloroquine
- hydroxyurea
- ibandronate: 2% - 7%
- ibuprofen: 10%
- icodextrin
- idarubicin: 68% - 73%
- ifosfamide: 1%
- iloperidone: 5% - 7%
- iloprost: postmarketing
- imatinib: very common, 0.464% - 70%
- imipramine
- imiquimod: uncommon, 0% - 2.79%
- indapamide: 2%
- indinavir: 2.1% - 24.6%
- indomethacin: 2% - 3%
- insulin detemir: 3.2% - 4.2%
- iodide
- iodixanol
- iohexol
- iopamidol
- iopromide: postmarketing
- iotrolan
- ioversol
- ioxilan
- ipratropium bromide: postmarketing, uncommon, 0.5% - 1.8%
- irbesartan: uncommon, 1.1% - 3.4%
- irbesartan-hydrochlorothiazide: 1.1% - 3.4%
- irinotecan: postmarketing, 1.6% - 88%
- iron sucrose: 2.7% - 16.5%
- isocarboxazid
- isomannide
- isosorbide-5-mononitrate
- isradipine: 1.1% - 1.9%
- itraconazole: postmarketing, 1.7% - 11%
- ivabradine
- ivacaftor: 12.8%
- ivermectin: 1.8%
- ixabepilone: 9% - 39%
- kanamycin
- ketoconazole
- ketoprofen
- ketorolac: 7%
- ketorolac tromethamine: postmarketing, 7%
- ketotifen
- labetalol: 0% - 2%
- lacosamide: 0% - 8%
- lactulose
- lamivudine: common, 2.62% - 22%
- lamotrigine: 4% - 11%
- lanreotide: postmarketing, 11.1% - 64.9%
- lansoprazole: postmarketing, 0% - 9%
- lanthanum
- lanthanum carbonate: 10% - 23%
- lapatinib: very common, 0% - 40%
- leflunomide: postmarketing, common, 10% - 27%
- lenalidomide: postmarketing, very common, 1.7% - 60.1%
- lercanidipine: common
- letrozole: common, 0.468% - 8%
- leucovorin: 11% - 67%
- leuprorelin acetate: 4.4% - 23.7%
- levetiracetam: 4.2% - 8%
- levobunolol
- levodopa/carbidopa: 1.2%
- levonorgestrel: 3.2% - 6.54%
- levosimendan
- linaclotide: 5%
- linagliptin: 3.28%
- lincomycin
- linezolid: 0.8% - 12.1%
- liraglutide: postmarketing, 8.9% - 17.1%
- lisdexamfetamine dimesylate: postmarketing, 7%
- lithium
- lithium carbonate
- lomefloxacin: 1.4%
- lomitapide
- loratadine
- lorcaserin: 6.48%
- losartan: 1.9% - 15%
- lovastatin: 2.2% - 2.6%
- lubiprostone: 7% - 12%
- lurasidone: frequent, 4%
- lymecycline
- mafenide acetate
- mannitol
- maprotiline
- maraviroc
- meclofenamate
- medroxyprogesterone
- medroxyprogesterone acetate
- mefenamic acid
- mefloquine: postmarketing
- megestrol: 6% - 15%
- megestrol acetate
- meloxicam: 0.6% - 9.2%
- melphalan: rare, very common
- memantine: 4.37% - 5%
- meprobamate
- meropenem: 2.5% - 7%
- mesna: 7.6% - 83%
- metaproterenol: 1.2% - 6%
- metformin: very common, 9.6% - 53.2%
- methadone
- methamphetamine
- methazolamide
- methotrexate
- methsuximide
- methyclothiazide
- methyldopa
- methylene blue
- methylergometrine
- methylnaltrexone: very common
- methylphenidate: 2.4%
- methylprednisolone
- methylprednisolone sodium succinate
- methysergide
- metoclopramide: postmarketing
- metolazone
- metoprolol: rare, common
- metronidazole: very rare, postmarketing, 1% - 10%
- mexiletine: 2.6% - 33.2%
- miconazole: 6% - 9%
- mifepristone: 12%
- miglitol: postmarketing
- miglustat: 0% - 100%
- milnacipran
- minocycline: 0% - 1.4%
- mirabegron: 1.2% - 1.5%
- mirtazapine: postmarketing
- misoprostol
- mitomycin C
- mitotane
- mitoxantrone: 8% - 47%
- moclobemide
- modafinil: postmarketing, 4%
- moexiprilat: 3.12%
- mometasone
- mometasone furoate
- monomethylfumarate: 14%
- monomycin
- montelukast: postmarketing
- morphine: 3%
- moxifloxacin: 0.5% - 6%
- moxonidine
- mupirocin
- mycophenolate mofetil: 9.1% - 51.3%
- mycophenolic acid: 2% - 51.3%
- nabilone
- nabumetone: 14%
- nadolol
- nafcillin
- nalidixic acid
- nalmefene
- naloxone
- naltrexone: postmarketing
- nandrolone
- naproxen: postmarketing
- naratriptan: infrequent
- nateglinide: common, 3.1% - 3.2%
- nebivolol: 2% - 3%
- nedocromil sodium
- nefazodone
- nelarabine: 0% - 22%
- nelfinavir: postmarketing, very common, 0% - 38.5%
- neomycin
- neostigmine: postmarketing
- nevirapine: common, 0.2% - 4%
- niacin: 10% - 14%
- nicardipine: 0.9%
- nicorandil: uncommon
- nicotine: 1.9%
- nifedipine
- nilotinib: 0% - 30%
- nilutamide: 2%
- nimodipine: 0%
- nisoldipine
- nitazoxanide: 2.1% - 4.3%
- nitrazepam
- nitrofurantoin
- nitrogen mustard
- nizatidine: postmarketing, 7.2% - 9.8%
- norfloxacin
- nortriptyline
- nystatin
- o291: 0.171%
- ofatumumab: 0% - 19%
- ofloxacin: 0.6%
- olanzapine: infrequent, 2% - 7%
- olmesartan: common, 0% - 1.86%
- olmesartan medoxomil
- olodaterol: 2.85%
- olopatadine: postmarketing
- olsalazine: 5.9%
- omeprazole: postmarketing, common, 2% - 28%
- ondansetron: 1.79% - 44%
- oseltamivir: 0.8% - 49%
- oxacillin
- oxaliplatin: postmarketing, very common, 1.5% - 85.9%
- oxaprozin
- oxcarbazepine: common, 2% - 7%
- oxprenolol
- oxybutynin: common, 2.3% - 7.9%
- oxycodone
- oxymetholone
- oxymorphone: 4% - 4.3%
- oxytetracycline
- paclitaxel: rare, 5% - 90%
- paliperidone
- palonosetron: 1.26% - 2.06%
- pamidronate: common, 0% - 29.4%
- pantoprazole: postmarketing, common, 1% - 18%
- papaverine
- paricalcitol: 6.5% - 11.5%
- paromomycin
- paroxetine: postmarketing, infrequent, uncommon, common, 0.9% - 19.2%
- pazopanib: 0% - 59%
- pegaptanib
- pegaptanib sodium
- pemetrexed: 0% - 34%
- penbutolol: 2.6% - 3.3%
- penciclovir: 1.6% - 9%
- penicillin V
- pentamidine
- pentazocine
- pentosan polysulfate: 3% - 4%
- pentostatin: 15% - 17%
- pentoxifylline: 3.4%
- pergolide: frequent, 6.4%
- perindopril: 4.3%
- perindopril erbumine: 4.3% - 4.6%
- permethrin
- perphenazine
- phencyclidine
- phendimetrazine
- phentermine
- phentolamine: common
- phenylazo
- phenytoin: infrequent
- phosphate
- pilocarpine: 4% - 7%
- pimecrolimus: 0.299% - 7.72%
- pimozide: 1%
- pinaverium bromide: 0.2%
- pindolol
- pioglitazone: 2.1% - 4.6%
- piperacillin: common
- pirbuterol: 0.7% - 1.3%
- pirfenidone
- piroxicam: 3.2%
- pitavastatin: 1.5% - 2.6%
- pixantrone
- poly(styrene sulfonate
- polyoxyethylene
- polythiazide
- pomalidomide: 33% - 33.6%
- ponatinib: 0% - 26%
- posaconazole: 10.4% - 32%
- potassium: postmarketing
- pralatrexate
- pramipexole: 1% - 7%
- prasugrel: 2.3% - 2.6%
- pravastatin: 0.9% - 6.7%
- praziquantel
- prazosin: 2%
- prednisolone phosphate
- prednisone
- pregabalin: postmarketing, rare, frequent, 1.1%
- procainamide
- procaine penicillin
- procarbazine
- progesterone: 4% - 8%
- proguanil
- promethazine
- propafenone: 0.4% - 39%
- propericiazine
- propofol
- propoxyphene
- propranolol: postmarketing, 4.5% - 6.3%
- prostacyclin: 5% - 50%
- prostaglandin
- protriptyline
- prucalopride: uncommon, very common
- pyrantel
- pyridostigmine: 7%
- quetiapine: 0.7% - 8%
- quinapril: 1.7%
- quinaprilat: 1.7%
- quinidine: 21% - 85%
- rabeprazole: postmarketing, 2.6% - 13%
- radium: 2% - 25%
- raloxifene: 7.2%
- raltegravir: postmarketing, 1.5% - 16.6%
- raltitrexed: 30-34%
- ramelteon: 2%
- ramipril: 1% - 1.1%
- ramiprilat: 1%
- ranitidine: 2%
- rapamycin: 5.1% - 42%
- rasagiline: 5% - 7%
- rasburicase: 0% - 29.6%
- reboxetine: 1.73%
- regadenoson: postmarketing, uncommon
- regorafenib
- remifentanil: 0.568% - 2.44%
- repaglinide: 4% - 6%
- reserpine
- retapamulin: 1.4% - 5%
- retinoic acid: postmarketing, 23%
- ribavirin: very common, 10% - 36%
- rifabutin: 3%
- rifampicin
- rifapentine
- rifaximin
- rilpivirine
- riluzole: 2.9% - 9%
- rimantadine
- rimonabant
- riociguat: 12%
- risedronate: rare, 4.7% - 19.7%
- risperidone: infrequent, 0.5% - 8%
- ritonavir: 0% - 25%
- rivaroxaban
- rivastigmine: common, frequent, very common, 1% - 19%
- rizatriptan: frequent
- rofecoxib: 6.5% - 10.6%
- roflumilast: 2.4% - 9.46%
- ropinirole: 3% - 5%
- ropivacaine: 0.1% - 4.9%
- rosiglitazone: 2.3% - 35%
- rosuvastatin
- rotigotine: 7%
- roxithromycin
- rufinamide
- sacrosidase
- salbutamol: 0% - 6%
- salicylate
- salmeterol
- salmon calcitonin acetate: postmarketing, uncommon, common
- salsalate
- samarium: 6.03%
- saquinavir: very common, 18%
- sertraline: postmarketing, common, 1% - 24%
- sevelamer: 5% - 19%
- sevelamer carbonate: 19%
- sevelamer hydrochloride: 4% - 22.8%
- sibutramine
- sildenafil: 1% - 18%
- silodosin: 2.58%
- simvastatin: 0.5% - 7.8%
- sitagliptin: postmarketing
- sitaxsentan: common
- sodium
- sodium cromoglycate
- sodium ferric gluconate: 2% - 35%
- sodium thiosulfate
- sofosbuvir: very common, 6% - 17%
- sorafenib: postmarketing, 0% - 55%
- sotalol: 1% - 7%
- sparfloxacin: postmarketing, 3.2% - 4.6%
- spironolactone
- stavudine: common, 44% - 50%
- streptozotocin: 10%
- strontium ranelate
- sugammadex
- sulfadiazine
- sulfamethoxazole
- sulfasalazine
- sulindac
- sumatriptan: infrequent, frequent
- sunitinib: 5%
- suvorexant: 2%
- tacrolimus: very common, 2% - 72%
- tadalafil: 1% - 11%
- tafamidis
- tamoxifen: 6.98% - 8.57%
- tamsulosin: postmarketing, uncommon, 4.27% - 6.2%
- tapentadol: postmarketing, 7%
- technetium-99m
- tegaserod: postmarketing, 4% - 9%
- telavancin: common, 7% - 8%
- telithromycin: 0.5% - 10.8%
- telmisartan: postmarketing, rare, uncommon, common, 2.6% - 3%
- temazepam: 1.1% - 1.7%
- temozolomide: common, 0% - 15.8%
- temsirolimus
- teniposide: 1% - 33%
- tenofovir: 5% - 16%
- tenofovir disoproxil fumarate: postmarketing, very common, 5.12% - 16%
- tenoxicam: common
- terazosin: 1%
- terbinafine: very common, 0% - 10%
- testosterone: postmarketing, 3% - 4%
- testosterone enanthate: postmarketing
- testosterone propionate
- testosterone undecanoate
- tetrabenazine
- tetracycline
- tetraen
- tetrahydrobiopterin: 8.11%
- thalidomide: 0% - 18.8%
- theophylline: 0% - 14%
- thiabendazole
- thiazide
- thioridazine
- thiotepa
- thiothixene
- thymidine: 1% - 5.9%
- thyroxine
- tiagabine: 2% - 10%
- tiaprofenic acid: 2.2% - 2.9%
- ticagrelor: 3.3% - 3.7%
- ticlopidine
- tigecycline: very common, 10.8% - 12.7%
- tiludronate
- timolol
- tinidazole
- tiopronin
- tipranavir: very common, 3.6% - 13.4%
- tizanidine: frequent
- tobramycin: common, 1.58% - 6.2%
- tofacitinib: 2.9% - 4%
- tolcapone: 16%
- tolmetin
- tolterodine: postmarketing
- tolvaptan: common
- topiramate: very rare, postmarketing, frequent, 2% - 14%
- topotecan: very common, 0% - 32%
- torasemide: 2%
- trabectedin
- tramadol: uncommon, 2.33% - 10%
- trametinib: 0% - 43%
- trandolapril: postmarketing, 0.2% - 1.1%
- trandolaprilat: 0.12%
- tranexamic acid: postmarketing
- tranylcypromine
- travoprost
- trazodone: 0% - 9.41%
- treprostinil: 0.0091% - 30%
- triamcinolone acetonide: 3%
- triamterene
- triazolam
- trimethobenzamide
- trimethoprim: common
- trimethoprim-sulfamethoxazole: common
- trimipramine
- tropisetron
- trovafloxacin: 2%
- umeclidinium
- ustekinumab: common, 2%
- v 1784: postmarketing, common, 1% - 13%
- valdecoxib: 3.9% - 10.8%
- valganciclovir: 6% - 41%
- valproate: 7% - 23%
- valrubicin
- valsartan: 2.5% - 5%
- vandetanib: 0.9% - 57%
- vardenafil
- varenicline: frequent
- vemurafenib: postmarketing, 1% - 29%
- venlafaxine: postmarketing, uncommon, 6% - 8%
- verapamil: postmarketing, 2.4%
- vernakalant: uncommon
- vigabatrin: 6% - 16%
- vilazodone: 28%
- vildagliptin: uncommon
- vinblastine
- vincristine: 37%
- vinflunine
- vinorelbine: 0% - 17%
- vismodegib: 0.7% - 29%
- voriconazole: very common, 0% - 3.24%
- vorinostat
- warfarin
- zafirlukast: 2.8%
- zalcitabine
- zanamivir: 2% - 3%
- ziconotide: 18%
- zidovudine: common, 6% - 14.9%
- zidovudine/lamivudine
- zileuton: 5%
- ziprasidone: 0% - 5%
- zoledronic acid: postmarketing, uncommon, 5.2% - 17%
- zolmitriptan: infrequent
- zolpidem: postmarketing, frequent, 1% - 3%
- zonisamide: 5%
- zopiclone: 2% - 4%
- zuclopenthixol
|
Drugs with this indication
|
